Goldman Sachs’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.28M Sell
648,074
-266,134
-29% -$2.17M ﹤0.01% 2752
2025
Q1
$7.18M Buy
914,208
+470,755
+106% +$3.7M ﹤0.01% 2476
2024
Q4
$6.6M Sell
443,453
-259,883
-37% -$3.87M ﹤0.01% 2643
2024
Q3
$10.8M Buy
703,336
+66,562
+10% +$1.02M ﹤0.01% 2185
2024
Q2
$9.7M Buy
636,774
+386,461
+154% +$5.89M ﹤0.01% 2112
2024
Q1
$4.73M Sell
250,313
-341,978
-58% -$6.46M ﹤0.01% 2611
2023
Q4
$11.3M Buy
592,291
+4,083
+0.7% +$78K ﹤0.01% 1972
2023
Q3
$10.6M Sell
588,208
-9,927
-2% -$178K ﹤0.01% 1946
2023
Q2
$12.1M Sell
598,135
-206,399
-26% -$4.19M ﹤0.01% 1886
2023
Q1
$14.7M Buy
804,534
+42,114
+6% +$768K ﹤0.01% 1733
2022
Q4
$15.8M Sell
762,420
-100,965
-12% -$2.09M ﹤0.01% 1792
2022
Q3
$22.6M Sell
863,385
-110,747
-11% -$2.9M 0.01% 1511
2022
Q2
$24.7M Buy
974,132
+727,692
+295% +$18.4M 0.01% 1466
2022
Q1
$7.78M Buy
246,440
+133,979
+119% +$4.23M ﹤0.01% 2452
2021
Q4
$4.55M Buy
112,461
+53,609
+91% +$2.17M ﹤0.01% 2880
2021
Q3
$2.05M Sell
58,852
-357,879
-86% -$12.5M ﹤0.01% 3467
2021
Q2
$11.4M Sell
416,731
-164,720
-28% -$4.52M ﹤0.01% 2153
2021
Q1
$16.3M Sell
581,451
-177,712
-23% -$4.99M ﹤0.01% 1823
2020
Q4
$19.7M Buy
759,163
+304,495
+67% +$7.9M 0.01% 1573
2020
Q3
$7.79M Sell
454,668
-95,699
-17% -$1.64M ﹤0.01% 2108
2020
Q2
$13.6M Buy
550,367
+467,011
+560% +$11.6M ﹤0.01% 1742
2020
Q1
$1.16M Sell
83,356
-39,079
-32% -$542K ﹤0.01% 3042
2019
Q4
$1.24M Buy
122,435
+28,982
+31% +$293K ﹤0.01% 3207
2019
Q3
$850K Buy
93,453
+738
+0.8% +$6.71K ﹤0.01% 3336
2019
Q2
$737K Buy
92,715
+48,563
+110% +$386K ﹤0.01% 3342
2019
Q1
$551K Buy
44,152
+4,074
+10% +$50.8K ﹤0.01% 3528
2018
Q4
$432K Buy
40,078
+21,863
+120% +$236K ﹤0.01% 3460
2018
Q3
$254K Sell
18,215
-10,638
-37% -$148K ﹤0.01% 3726
2018
Q2
$353K Sell
28,853
-100,172
-78% -$1.23M ﹤0.01% 3661
2018
Q1
$1.99M Buy
+129,025
New +$1.99M ﹤0.01% 2878